Breast carcinoma metastasis to the serosal cavities represents an advanced stage in tumor progression and is associated with extensive alterations at the molecular level, involving clinically established targets such as HER-2 and hormone receptors, as well as other cancer-associated molecules [7–10]. The gene discussed is NR4A1; the disease is neoplasm.